Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

Mechanisms of human mRNA packaging and export

Project description

Dissecting the mechanism of mRNA export from the nucleus

Transport in and out of the nucleus is a highly selective process carried out by a specific set of proteins. In terms of mRNA, it must undergo full processing and maturation in the nucleus before crossing the nuclear envelope. The EU-funded RNApaxport project aims to shed light on the mechanism of this mRNA transport specificity. In particular, scientists will investigate how a defined set of conserved proteins package and export all nuclear mRNA. For this purpose, they will examine the organisation, dynamics and function of key packaging factors. Insight into the role of mRNA length and sequence will help understand the complex mechanisms of gene expression.

Objective

Eukaryotic gene expression is partitioned across two cellular compartments: the nucleus, where messenger RNA (mRNA) is produced, and the cytoplasm, where protein translation occurs. mRNA export across the nuclear membrane is highly selective, ensuring that only fully processed and mature mRNA is transported to the cytoplasm. Yet how does the multi-step mRNA maturation process converge to a binary decision, ‘to export or not to export’? While we know many of the proteins involved in packaging and export of nuclear mRNA ribonucleoprotein complexes (mRNPs), how a defined set of conserved proteins package and export all nuclear mRNA remains poorly understood. To reveal how specificity towards mature mRNA is achieved and to identify regulatory checkpoints, I propose to visualize key mRNP intermediates using a state-of-the-art integrative structural biology approach. First, we will determine the human THO/TREX complex structure to reveal how this key packaging factor is organized and brought to mRNA (aim 1). Second, we will determine the structure of a human mRNP 5’-end to explain how two key features of mature mRNPs, the 5’-cap and the first splice junction, are recognized and integrated by THO/TREX to achieve export competence (aim 2). Third, we will obtain the architecture of endogenous human mRNPs to reveal their dynamics and to determine how mRNAs of varied length and sequence are packaged (aim 3). These data will enable the complementary and targeted in vitro and in vivo structure-function analysis. Taken together, the expected results will reveal novel insights into the mechanisms that underlie an important step of gene expression, which mediates nuclear mRNA quality control and links transcription to translation. My background in structural biology, mRNA transcription and processing is ideally suited to carry out this high-impact proposal.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

ERC-STG - Starting Grant

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) ERC-2020-STG

See all projects funded under this call

Host institution

FORSCHUNGSINSTITUT FUR MOLEKULARE PATHOLOGIE GESELLSCHAFT MBH
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 1 500 000,00
Address
CAMPUS-VIENNA-BIOCENTER 1
1030 Wien
Austria

See on map

Region
Ostösterreich Wien Wien
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

€ 1 500 000,00

Beneficiaries (1)

My booklet 0 0